| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | President & CEO | Ordinary Shares | 115,230 | $19,722,766 | $171.16 | 16 Jan 2026 | Direct |
| DEXCOM INC | Director | Common Stock | 6,881 | $582,614 | $84.67 | 08 May 2025 | Direct |
| Gossamer Bio, Inc. | Director | Stock Option (Right to Buy) | 35,000 | 08 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | 16 Jan 2026 | 2 | -$919,300 | 4 | President & CEO | 21 Jan 2026, 19:49 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Dec 2025 | 1 | -$13,353 | 4 | President & CEO | 09 Dec 2025, 18:24 |
| JAZZ | Jazz Pharmaceuticals plc | 07 Aug 2025 | 1 | $0 | 4 | President & CEO | 11 Aug 2025, 17:31 |
| DXCM | DEXCOM INC | 08 May 2025 | 1 | $0 | 4/A | Director | 07 Jul 2025, 16:15 |
| DXCM | DEXCOM INC | 06 Mar 2025 | 1 | $0 | 4 | Director | 10 Mar 2025, 17:01 |
| DXCM | DEXCOM INC | 06 Mar 2025 | 0 | $0 | 3 | Director | 10 Mar 2025, 16:46 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Mar 2025 | 1 | -$792,571 | 4 | President & COO | 07 Mar 2025, 18:45 |
| JAZZ | Jazz Pharmaceuticals plc | 27 Feb 2025 | 2 | $0 | 4 | President & COO | 03 Mar 2025, 19:29 |
| JAZZ | Jazz Pharmaceuticals plc | 17 Jan 2025 | 2 | -$404,646 | 4 | President & COO | 22 Jan 2025, 18:50 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Dec 2024 | 1 | -$9,876 | 4 | President & COO | 09 Dec 2024, 18:45 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Apr 2024 | 1 | -$200,005 | 4 | President & COO | 09 Apr 2024, 16:39 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Mar 2024 | 1 | -$425,694 | 4 | President & COO | 07 Mar 2024, 21:53 |
| JAZZ | Jazz Pharmaceuticals plc | 01 Mar 2024 | 1 | $0 | 4 | President & COO | 05 Mar 2024, 19:44 |
| JAZZ | Jazz Pharmaceuticals plc | 17 Jan 2024 | 2 | -$381,693 | 4 | President & COO | 19 Jan 2024, 18:23 |
| JAZZ | Jazz Pharmaceuticals plc | 10 Nov 2023 | 1 | $0 | 4 | President & COO | 14 Nov 2023, 17:50 |
| GOSS | Gossamer Bio, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:15 |
| JAZZ | Jazz Pharmaceuticals plc | 18 May 2023 | 1 | -$790,474 | 4 | EVP & Chief Financial Officer | 19 May 2023, 20:45 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Apr 2023 | 1 | -$263,424 | 4 | EVP & Chief Financial Officer | 07 Apr 2023, 17:44 |
| JAZZ | Jazz Pharmaceuticals plc | 03 Mar 2023 | 2 | -$222,308 | 4 | EVP & Chief Financial Officer | 07 Mar 2023, 20:14 |
| JAZZ | Jazz Pharmaceuticals plc | 21 Dec 2022 | 1 | -$421,600 | 4 | EVP & Chief Financial Officer | 22 Dec 2022, 15:53 |
| GOSS | Gossamer Bio, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 15 Jul 2022, 16:52 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Apr 2022 | 1 | -$265,983 | 4 | EVP & CFO | 07 Apr 2022, 16:17 |
| JAZZ | Jazz Pharmaceuticals plc | 03 Mar 2022 | 2 | -$110,851 | 4 | EVP & CFO | 09 Mar 2022, 16:53 |
| GOSS | Gossamer Bio, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 19:52 |